Background Image
Menu

News: 2020

Pill Connect expands its team with the appointment of Richard Hall as Director of Quality

16 December 2020

Pill Connect expands its team with the appointment of Richard Hall as Director of Quality

Pill Connect (formerly known as Elucid Mhealth), a world leader in medicine adherence monitoring and data capture on patient compliance, has expanded its team with the appointment of Richard Hall as Director of Quality. This follows the recent successful funding raise involving...

Catapult Ventures invests in OVO Biomanufacturing to improve the manufacturing efficiency of viral vaccines and gene therapies

8 December 2020

Catapult Ventures invests in OVO Biomanufacturing to improve the manufacturing efficiency of viral vaccines and gene therapies

3rd December 2020 - Alderley Park, UK. OVO Biomanufacturing today announced the completion of a new funding round to develop its novel technology platform to improve the manufacturing efficiency for viral vaccines and gene therapies. The funding came from the GM&C Life...

Exciting new collaboration to develop fully synthetic animal-free scaffolds

26 November 2020

Exciting new collaboration to develop fully synthetic animal-free scaffolds

Three UK biotechnology companies will combine research expertise to develop fully synthetic animal-free scaffolds overcoming barriers in sustainable and scalable organoid culture in a project funded by Innovate UK. Cardiff-based organoid company, Cellesce, Peptide 3D scaffold...

Maven Equity Finance NPIF invests alongside Catapult in digital healthcare consent platform Flynotes

24 November 2020

Maven Equity Finance NPIF invests alongside Catapult in digital healthcare consent platform Flynotes

A Manchester-based digital healthcare consent platform has secured funding from NPIF - Maven Equity Finance. Flynotes is behind a platform which provides a digital alternative to the paper-based consent and disclosure process. Having developed its product, the company is...

Maxwellia looking into daily contraceptive Rx-To-OTC switch

23 November 2020

Maxwellia looking into daily contraceptive Rx-To-OTC switch

As calls for a non-prescription daily contraceptive pill grow in the UK, switch incubator Maxwellia suggests an Rx-to-OTC reclassification of the widely-used progestogen only pill may be one of its first "switch-in-a-box" projects. Responding to a growing demand in the UK for...

Digi.me partners with Gendius to allow users to connect their health records to its smart diabetes management platform

18 November 2020

Digi.me partners with Gendius to allow users to connect their health records to its smart diabetes management platform

Digi.me is partnering with British digital health start-up Gendius to allow users to connect their health records to its smart diabetes platform, Intellin®. The deal will mean that digi.me users in the UK will be able to download and consent to share their NHS GP health...

Cytox publishes research showing genoSCORE-LAB test can predict risk of cognitive decline due to Alzheimer’s without invasive procedures

17 November 2020

Cytox publishes research showing genoSCORE-LAB test can predict risk of cognitive decline due to Alzheimer’s without invasive procedures

genoSCORE™-LAB a new genetic test to launch in 2020 enables early assessment of patients with cognitive complaints from a simple saliva or blood sample … 17th November 2020: Oxford and Manchester, UK. Cytox Ltd, which provides non-invasive, risk assessment and patient...

The Medication Adherence Expertise Center and Pill Connect’s smart adherence system help patients with TB take their medication regularly

9 November 2020

The Medication Adherence Expertise Center and Pill Connect’s smart adherence system help patients with TB take their medication regularly

A pilot trial at The Medication Adherence Expertise Center of the University Medical Center Groningen in the Netherlands is determining whether Pill Connect’s smart bottle system can support patients with tuberculosis (TB) with their medication adherence. TB remains one of...

Infex Therapeutics and LifeArc announce collaboration to defeat superbugs

5 November 2020

Infex Therapeutics and LifeArc announce collaboration to defeat superbugs

Infex Therapeutics has combined forces with medical research charity, LifeArc, to develop the next generation of drugs to treat serious infections caused by superbugs. The collaboration will see Infex Therapeutics develop innovative antimicrobial compounds against...

Biorelate - AI-based drug discovery tool free access extended

4 November 2020

Biorelate - AI-based drug discovery tool free access extended

As the world enters a new wave of lockdowns, Biorelate, a Manchester-based AI start up, extends its free use of Galactic to all researchers. To aid researchers as they try to adapt to the ‘new normal’ caused by COVID-19, Biorelate has been offering free use of its...